Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a system release rather than a change to the displayed study record.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0 revision.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:41.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the Record History to reflect the latest site release.
    Difference
    0.1%
    Check dated 2026-03-19T19:08:25.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the record history, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T10:39:29.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T16:27:57.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting updates. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T10:41:39.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.